C12Y 304/22033
Fruit bromelain , i.e. juice bromelain
Official title: Fruit bromelain (3.4.22.33), i.e. juice bromelain
C12Y304/22033 (Fruit bromelain , i.e. juice bromelain) appears on 35 US grants and 69 published applications in this corpus.
Search patents in C12Y- Granted patents
- 35
- Published applications
- 69
- Assignees
- 42
- Inventors
- 92
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 1 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 3 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 2 | 5 |
| 2012 | 0 | 1 |
| 2013 | 2 | 1 |
| 2014 | 4 | 2 |
| 2015 | 0 | 3 |
| 2016 | 1 | 3 |
| 2017 | 1 | 8 |
| 2018 | 4 | 7 |
| 2019 | 3 | 6 |
| 2020 | 5 | 3 |
| 2021 | 3 | 4 |
| 2022 | 2 | 2 |
| 2023 | 3 | 5 |
| 2024 | 1 | 4 |
| 2025 | 0 | 2 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bromelain protease, bromelain, jacalin-like lectin, extract from the stem and/or the fruit of a pineapple plant, combination preparation, bromelain protease inhibitor, protein/protease mix, and glycated bromelain protein formed by exogenous non-enzymatic glycation, for use in the treatment or prophylaxis of virus infections caused by coronaviruses in a human or animal15 Sep 2026US 12,734,223 B2Helmholtz-Institut FüR Pharmazeutische Forschung Saarland
- Implantable device for sustained release of a macromolecular drug compound1 Oct 2024US 12,108,225 B2Celanese EVA Performance Polymers LLC
- Implantable device for sustained release of a macromolecular drug compound4 Jul 2023US 11,690,806 B2Celanese EVA Performance Polymers LLC
- Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones27 Jun 2023US 11,689,849 B2Nureva, Inc.
- Systems for treating dermal inflammatory conditions28 Feb 2023US 11,590,211 B2Nuvothera, Inc.
- Methods for developing companion supplements for dogs, related compositions, and systems17 Sep 2026US 2026/0272876 A1Life's Abundance
- Enhancement and stabilisation of proteolytic activity of proteases6 Aug 2026US 2026/0226451 A1Phoenix Eagle Company Pty. Ltd.
- Implantable Device for Sustained Release of a Macromolecular Drug Compound26 Feb 2026US 2026/0059238 A1Celanese EVA Performance Polymers LLC
- Powder and liquid compositions for dental care, and methods of use thereof11 Sep 2025US 2025/0281373 A1More Group Pty. Ltd.
- Methods for treating respiratory diseases9 Jan 2025US 2025/0009856 A1Mucpharm Pty Ltd
Most cited
By later US patents
- Dietary supplements and methods for treating pain and inflammation10US 6,713,096 B2Melaleuca, Inc. · 2004
- Formulations including digestive enzymes, polysorbate-based surfactants and probiotics9US 8,722,035 B2Master Supplements, Inc. · 2014
- Dietary supplements and methods for treating pain and inflammation8US 7,138,149 B2Melaleuca, Inc. · 2006
- Formulations including digestive enzymes and polysorbate surfactants that enhance the colonization of administered probiotics microoganisms7US 8,066,986 B2Master Supplements, Inc. · 2011
- Enzymatic debridement therapy for abnormal cell proliferation7US 8,754,045 B22014